Genedata Launches Fully Integrated Electronic Lab Notebook to Help Biopharma R&D Teams Move Faster
New ELN connects experimental context and structured scientific data across R&D workflows, creating an AI-ready foundation for faster, more informed decisions BASEL, Switzerland, Oct. 28, 2026 /PRNewswire/ -- Genedata, a Danaher company and leading provider of enterprise software for...
Covered in this story
Analyst targets on Danaher Corporation
- UBS: $205 → $250 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DHR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Danaher Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.